This week, Kate, Henry and Mark discuss pharmacotherapy for alcohol use disorder, using opioids in adults with cancer pain who also use non-medical stimulants, and brexpiprazole for agitation in patients with Alzheimer's dementia.

This week, Kate, Henry and Mark discuss pharmacotherapy for alcohol use disorder, using opioids in adults with cancer pain who also use non-medical stimulants, and brexpiprazole for agitation in patients with Alzheimer's dementia.

Episode 148: meds for alcohol withdrawal, opioids and stimulants, and treating agitation in AD

Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.

Share Episode 148: meds for alcohol withdrawal, opioids and stimulants, and treating agitation in AD

Sign up to save your podcasts

Episode 148: meds for alcohol withdrawal, opioids and stimulants, and treating agitation in AD

Episode 148: meds for alcohol withdrawal, opioids and stimulants, and treating agitation in AD